Found 8 matching trials
Determination 2 - Isatuximab, Iberdomide, Bortezomib and Dexamethasone Induction, Followed by Risk- and Response-Adapted Consolidation and Maintenance Therapy, in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma PHASE3 The purpose of the study is to determine the best treatment approach based ...
Show More Location
Beth Israel Deaconess Medical Center (BIDMC)
Learn More & Join Trial
Bendamustine Combined With Chidamide and Lenalidomide for Relapsed and Refractory PTCL Patients NA To evaluate the efficacy and safety of bendamustine combined with chidamide...
Show More Location
The First Affiliated Hospital of Soochow University
Learn More & Join Trial
Safety and Efficacy Trial of Epcoritamab Combinations in Subjects With B-cell Non-Hodgkin Lymphoma (B-NHL) PHASE1 The purpose of this trial is to measure the safety and effectiveness of epc...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Treatments Being Tested
rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone rituximab and lenalidomide rituximab and bendamustine rituximab, cytarabine, dexamethasone, and oxaliplatin/carboplatin gemcitabine and oxaliplatin Epcoritamab rituximab, cyclophosphamide, reduced dose of doxorubicin, vincristine, and prednisone Lenalidomide rituximab, ifosfamide, carboplatin, and etoposide phosphate Epcoritamab Epcoritamab Epcoritamab Epcoritamab Epcoritamab Epcoritamab Epcoritamab Rituximab and Lenalidomide Epcoritamab Learn More & Join Trial
Combination Regimen of Teniposide, PD-1 Monoclonal Antibody and Selinixor for Patients With Relapsed or Refractory PCNSL NA This study aims to evaluate the efficacy and safety of the VPX regimen, a n...
Show More Location
The First Affiliated Hospital of Soochow University
Learn More & Join Trial
Validating DW-MRI and Fat Fraction in Multiple Myeloma Post-ASCT: The RAC-FAT Study" N/A This is a multicenter, observational, retrospective-prospective study desig...
Show More Location
IRCCS Istituto Tumori "G. Paolo II - U.O.C. Ematologia e Terapia Cellulare
Learn More & Join Trial
Redirected Auto T Cells for Advanced Myeloma PHASE2 The purpose of this study is to 1) evaluate the safety and tolerability of ...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Dasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic Malignancies PHASE1 This study uses a drug called dasatinib to produce an anti-cancer effect ca...
Show More Location
Barbara Ann Karmanos Cancer Institute
Learn More & Join Trial
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment PHASE1 This study is researching an experimental drug called linvoseltamab (called...
Show More Location
University of California Los Angeles (UCLA)
Learn More & Join Trial